Faithward Advisors’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $37.2K | Hold |
30,000
| – | – | 0.01% | 264 |
|
|
2025
Q1 | $35.4K | Hold |
30,000
| – | – | 0.01% | 259 |
|
|
2024
Q4 | $54.9K | Hold |
30,000
| – | – | 0.01% | 251 |
|
|
2024
Q3 | $51K | Hold |
30,000
| – | – | 0.01% | 278 |
|
|
2024
Q2 | $41.1K | Hold |
30,000
| – | – | 0.01% | 250 |
|
|
2024
Q1 | $113K | Hold |
30,000
| – | – | 0.02% | 249 |
|
|
2023
Q4 | $193K | Buy |
30,000
+7,000
| +30% | +$45.1K | 0.04% | 166 |
|
|
2023
Q3 | $148K | Buy |
23,000
+4,000
| +21% | +$25.8K | 0.04% | 162 |
|
|
2023
Q2 | $219K | Buy |
19,000
+1,000
| +6% | +$11.6K | 0.05% | 158 |
|
|
2023
Q1 | $219K | Hold |
18,000
| – | – | 0.05% | 173 |
|
|
2022
Q4 | $147K | Hold |
18,000
| – | – | 0.03% | 151 |
|
|
2022
Q3 | $104K | Hold |
18,000
| – | – | 0.02% | 144 |
|
|
2022
Q2 | $80K | Hold |
18,000
| – | – | 0.02% | 170 |
|
|
2022
Q1 | $164K | Buy |
18,000
+5,000
| +38% | +$45.6K | 0.03% | 163 |
|
|
2021
Q4 | $266K | Sell |
13,000
-7,500
| -37% | -$153K | 0.05% | 139 |
|
|
2021
Q3 | $524K | Buy |
20,500
+9,500
| +86% | +$243K | 0.1% | 101 |
|
|
2021
Q2 | $385K | Buy |
+11,000
| New | +$385K | 0.08% | 116 |
|
|
2021
Q1 | – | Sell |
-11,000
| Closed | -$285K | – | 254 |
|
|
2020
Q4 | $285K | Sell |
11,000
-11,500
| -51% | -$298K | 0.12% | 67 |
|
|
2020
Q3 | $222K | Buy |
+22,500
| New | +$222K | 0.05% | 127 |
|